![Effects of a hemoglobin-based oxygen carrier (HBOC-201) and derivatives with altered oxygen affinity and viscosity on systemic and microcirculatory variables in a top-load rat model - ScienceDirect Effects of a hemoglobin-based oxygen carrier (HBOC-201) and derivatives with altered oxygen affinity and viscosity on systemic and microcirculatory variables in a top-load rat model - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0026286214001095-gr1.jpg)
Effects of a hemoglobin-based oxygen carrier (HBOC-201) and derivatives with altered oxygen affinity and viscosity on systemic and microcirculatory variables in a top-load rat model - ScienceDirect
Adjusted cADP means were compared in two treatment groups, HBOC-201 and... | Download Scientific Diagram
![PDF) Oxidation and haem loss kinetics of poly(ethylene glycol)-conjugated haemoglobin (MP4): Dissociation between in vitro and in vivo oxidation rates PDF) Oxidation and haem loss kinetics of poly(ethylene glycol)-conjugated haemoglobin (MP4): Dissociation between in vitro and in vivo oxidation rates](https://i1.rgstatic.net/publication/6970391_Oxidation_and_haem_loss_kinetics_of_polyethylene_glycol-conjugated_haemoglobin_MP4_Dissociation_between_in_vitro_and_in_vivo_oxidation_rates/links/00463529b67ec126a7000000/largepreview.png)
PDF) Oxidation and haem loss kinetics of poly(ethylene glycol)-conjugated haemoglobin (MP4): Dissociation between in vitro and in vivo oxidation rates
![Does OxyVita, a New-Generation Hemoglobin-Based Oxygen Carrier, or Oxyglobin Acutely Interfere With Coagulation Compared With Normal Saline or 6% Hetastarch? An Ex Vivo Thromboelastography Study - Journal of Cardiothoracic and Vascular Anesthesia Does OxyVita, a New-Generation Hemoglobin-Based Oxygen Carrier, or Oxyglobin Acutely Interfere With Coagulation Compared With Normal Saline or 6% Hetastarch? An Ex Vivo Thromboelastography Study - Journal of Cardiothoracic and Vascular Anesthesia](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/db7593c9-1495-4ae3-82c0-82cf178bef90/gr5_lrg.jpg)
Does OxyVita, a New-Generation Hemoglobin-Based Oxygen Carrier, or Oxyglobin Acutely Interfere With Coagulation Compared With Normal Saline or 6% Hetastarch? An Ex Vivo Thromboelastography Study - Journal of Cardiothoracic and Vascular Anesthesia
![Oxidation and haem loss kinetics of poly(ethylene glycol)-conjugated haemoglobin (MP4): dissociation between in vitro and in vivo oxidation rates. - Abstract - Europe PMC Oxidation and haem loss kinetics of poly(ethylene glycol)-conjugated haemoglobin (MP4): dissociation between in vitro and in vivo oxidation rates. - Abstract - Europe PMC](https://europepmc.org/articles/PMC1615902/bin/bic792i004.jpg)
Oxidation and haem loss kinetics of poly(ethylene glycol)-conjugated haemoglobin (MP4): dissociation between in vitro and in vivo oxidation rates. - Abstract - Europe PMC
Model-based evaluation of the microhemodynamic effects of PEGylated HBOC molecules in the rat brain cortex: a laser speckle imaging study
![Impact of Hemoglobin Concentration and Affinity for Oxygen on Tissue Oxygenation: The Case of Hemoglobin‐Based Oxygen Carriers - Samaja - 2012 - Artificial Organs - Wiley Online Library Impact of Hemoglobin Concentration and Affinity for Oxygen on Tissue Oxygenation: The Case of Hemoglobin‐Based Oxygen Carriers - Samaja - 2012 - Artificial Organs - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/e7c4d7c1-4c26-4e9e-b3ad-b549d481d3ab/aor_1296_f1.gif)
Impact of Hemoglobin Concentration and Affinity for Oxygen on Tissue Oxygenation: The Case of Hemoglobin‐Based Oxygen Carriers - Samaja - 2012 - Artificial Organs - Wiley Online Library
![Hemoglobin-based Oxygen Carriers: First, Second or Third Generation? Human or Bovine? Where are we Now? - Critical Care Clinics Hemoglobin-based Oxygen Carriers: First, Second or Third Generation? Human or Bovine? Where are we Now? - Critical Care Clinics](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/0ab0095d-ec18-4ff5-99f0-399cbc153799/gr2_lrg.jpg)
Hemoglobin-based Oxygen Carriers: First, Second or Third Generation? Human or Bovine? Where are we Now? - Critical Care Clinics
![Breast-Ovarian Cancer, Familial 2 disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials Breast-Ovarian Cancer, Familial 2 disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials](http://malacards.blob.core.windows.net/network-images-v5-8-10/breast_ovarian_cancer_familial_2_2_related_diseases.jpg)
Breast-Ovarian Cancer, Familial 2 disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials
![Biomolecules | Free Full-Text | Hemoglobin-Based Blood Substitutes and the Treatment of Sickle Cell Disease: More Harm than Help? | HTML Biomolecules | Free Full-Text | Hemoglobin-Based Blood Substitutes and the Treatment of Sickle Cell Disease: More Harm than Help? | HTML](https://www.mdpi.com/biomolecules/biomolecules-07-00002/article_deploy/html/images/biomolecules-07-00002-g001.png)
Biomolecules | Free Full-Text | Hemoglobin-Based Blood Substitutes and the Treatment of Sickle Cell Disease: More Harm than Help? | HTML
Model-based evaluation of the microhemodynamic effects of PEGylated HBOC molecules in the rat brain cortex: a laser speckle imaging study
![Microparticle, nanoparticle, and stem cell-based oxygen carriers as advanced blood substitutes: Trends in Biotechnology Microparticle, nanoparticle, and stem cell-based oxygen carriers as advanced blood substitutes: Trends in Biotechnology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2017518474/2037789599/gr3.jpg)
Microparticle, nanoparticle, and stem cell-based oxygen carriers as advanced blood substitutes: Trends in Biotechnology
Model-based evaluation of the microhemodynamic effects of PEGylated HBOC molecules in the rat brain cortex: a laser speckle imaging study
![Exploring Oxidative Reactions in Hemoglobin Variants Using Mass Spectrometry: Lessons for Engineering Oxidatively Stable Oxygen Therapeutics | Antioxidants & Redox Signaling Exploring Oxidative Reactions in Hemoglobin Variants Using Mass Spectrometry: Lessons for Engineering Oxidatively Stable Oxygen Therapeutics | Antioxidants & Redox Signaling](https://www.liebertpub.com/cms/10.1089/ars.2016.6805/asset/images/medium/figure1.gif)
Exploring Oxidative Reactions in Hemoglobin Variants Using Mass Spectrometry: Lessons for Engineering Oxidatively Stable Oxygen Therapeutics | Antioxidants & Redox Signaling
![Effects of a hemoglobin-based oxygen carrier (HBOC-201) and derivatives with altered oxygen affinity and viscosity on systemic and microcirculatory variables in a top-load rat model - ScienceDirect Effects of a hemoglobin-based oxygen carrier (HBOC-201) and derivatives with altered oxygen affinity and viscosity on systemic and microcirculatory variables in a top-load rat model - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0026286214001095-gr3.jpg)
Effects of a hemoglobin-based oxygen carrier (HBOC-201) and derivatives with altered oxygen affinity and viscosity on systemic and microcirculatory variables in a top-load rat model - ScienceDirect
![PDF] A phase I single blind clinical trial of a new oxygen transport agent ( MP4), human hemoglobin modified with maleimide-activated polyethylene glycol. | Semantic Scholar PDF] A phase I single blind clinical trial of a new oxygen transport agent ( MP4), human hemoglobin modified with maleimide-activated polyethylene glycol. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f9a9dab9236a3f7d9bf7551281a0be034d8fdc6b/5-Table1-1.png)
PDF] A phase I single blind clinical trial of a new oxygen transport agent ( MP4), human hemoglobin modified with maleimide-activated polyethylene glycol. | Semantic Scholar
![Targeted Oxygen Delivery within Hepatic Hollow Fiber Bioreactors via Supplementation of Hemoglobin‐Based Oxygen Carriers - Sullivan - 2006 - Biotechnology Progress - Wiley Online Library Targeted Oxygen Delivery within Hepatic Hollow Fiber Bioreactors via Supplementation of Hemoglobin‐Based Oxygen Carriers - Sullivan - 2006 - Biotechnology Progress - Wiley Online Library](https://aiche.onlinelibrary.wiley.com/cms/asset/0376e4dd-0350-4264-87cd-5df1fc93ba98/mfig006.gif)